Related references
Note: Only part of the references are listed.Early onset lung cancer, cigarette smoking and the SNP309 of the murine double minute-2 (MDM2) gene
Kirstin Mittelstrass et al.
BMC CANCER (2008)
Do genetic factors protect for early onset lung cancer?: A case control study before the age of 50 years
Albert Rosenberger et al.
BMC CANCER (2008)
Matrix metalloproteinase 1 (MMP1) is associated with early-onset lung cancer
Wiebke Sauter et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
CYP1A1, GSTM1, and GSTT1 polymorphisms, smoking, and lung cancer risk in a pooled analysis among Asian populations
Kyoung-Mu Lee et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers
Shanbeh Zienolddiny et al.
CARCINOGENESIS (2008)
Molecular epidemiology to better predict lung cancer risk
Mary E. Reid et al.
CLINICAL LUNG CANCER (2008)
CyP1B1, CYP1A1, MPO, and GSTP1 polymorphisms and lung cancer risk in never-smoking Korean women
Kyong-Ah Yoon et al.
LUNG CANCER (2008)
CYP1A1 and GSTM1 polymorphisms and lung cancer risk in Chinese populations:: A meta-analysis
Xiuquan Shi et al.
LUNG CANCER (2008)
A variant associated with nicotine dependence, lung cancer and peripheral arterial disease
Thorgeir E. Thorgeirsson et al.
NATURE (2008)
A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25
Rayjean J. Hung et al.
NATURE (2008)
Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1
Christopher I. Amos et al.
NATURE GENETICS (2008)
It's all about sex: gender, lung development and lung disease
Michelle A. Carey et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2007)
The impact of sex and sex hormones on lung physiology and disease: lessons from animal studies
Michelle A. Carey et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Genetic susceptibility according to three metabolic pathways in cancers of the lung and bladder and in myeloid leukemias in nonsmokers
P. Vineis et al.
ANNALS OF ONCOLOGY (2007)
Development of lung cancer before the age of 50: the role of xenobiotic metabolizing genes
Federica Gemignani et al.
CARCINOGENESIS (2007)
Combinations of cytochrome P-450 genotypes and risk of early-onset lung cancer in Caucasians and African Americans: A population-based study
M. L. Cote et al.
LUNG CANCER (2007)
Meta- and pooled analyses of the cytochrome P-4501B1 Val432Leu polymorphism and breast cancer: A HuGE-GSEC review
Valentina Paracchini et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis
Daniel W. Nebert et al.
NATURE REVIEWS CANCER (2006)
Significant association of a M129V independent polymorphism in the 5′ UTR of the PRNP gene with sporadic Creutzfeldt-Jakob disease in a large German case-control study
C. Vollmert et al.
JOURNAL OF MEDICAL GENETICS (2006)
Sex differences in risk of lung cancer:: Expression of genes in the PAH bioactivation pathway in relation to smoking and bulky DNA adducts
Steen Mollerup et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
An epidemiologic study of early onset lung cancer
CJ Etzel et al.
LUNG CANCER (2006)
Clinical implications of CYP3A polymorphisms
Leszek Wojnowski et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2006)
Role of polymorphic human cytochrome P450 enzymes in estrone oxidation
AE Cribb et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
SNP-based analysis of genetic substructure in the German population
Michael Steffens et al.
HUMAN HEREDITY (2006)
Metabolic gene polymorphisms and lung cancer risk in non-smokers -: An update of the GSEC study
S Raimondi et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2005)
Cytochrome P450-mediated metabolism of estrogens and its regulation in human
Y Tsuchiya et al.
CANCER LETTERS (2005)
KORA-gen - Resource for population genetics, controls and a broad spectrum of disease phenotypes
HE Wichmann et al.
GESUNDHEITSWESEN (2005)
KORA -: A research platform for population based health research
R Holle et al.
GESUNDHEITSWESEN (2005)
Risk of non-small cell lung cancer and the cytochrome P4501A1 Ile462Val polymorphism
JE Larsen et al.
CANCER CAUSES & CONTROL (2005)
Genetic polymorphisms in CYP1B1, GSTA1, NQO1 and NAT2 and the risk of lung cancer
M Sorensen et al.
CANCER LETTERS (2005)
Expression of cytochromes P450 1A1 and 1B1 in human lung from smokers, non-smokers, and ex-smokers
JH Kim et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2004)
Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1
T Shimada et al.
CANCER SCIENCE (2004)
The CYP3A4*1B allele increases risk for small cell lung cancer:: effect of gender and smoking dose
H Dally et al.
PHARMACOGENETICS (2003)
Single nucleotide polymorphisms of the human CYP2A13 gene:: Evidence for a null allele
XL Zhang et al.
DRUG METABOLISM AND DISPOSITION (2003)
CYP1A1 T3801C polymorphism and lung cancer:: A pooled analysis of 2,451 cases and 3,358 controls
P Vineis et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers:: a pooled analysis
RJ Hung et al.
CARCINOGENESIS (2003)
Trends in cigarette smoking in the German centers of the European Prospective Investigation into Cancer and Nutrition (EPIC): the influence of the educational level
S Rohrmann et al.
PREVENTIVE MEDICINE (2003)
Genetic Polymorphisms of the human CYP2A13 gene: Identification of single-nucleotide polymorphisms and functional characterization of an Arg257Cys variant
XL Zhang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Sample size requirements for matched case-control studies of gene-environment interaction
WJ Gauderman
STATISTICS IN MEDICINE (2002)
Polymorphisms in P450CYP1B1 affect the conversion of estradiol to the potentially carcinogenic metabolite 4-hydroxyestradiol
DN Li et al.
PHARMACOGENETICS (2000)
Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer
J Watanabe et al.
PHARMACOGENETICS (2000)
CYP1A1 polymorphisms and lung cancer risk: a meta-analysis
RS Houlston
PHARMACOGENETICS (2000)
Share Paper
